NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence-free interval (IBCR-FI) in patients (pts) with positive axillary (PAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC).

Authors

Eleftherios P. Mamounas

NSABP/NRG Oncology, and Orlando Health UF Cancer Center, Orlando, FL

Eleftherios P. Mamounas , Hanna Bandos , Julia R. White , Thomas B. Julian , Atif J. Khan , Simona Flora Shaitelman , Mylin Ann Torres , Frank Vicini , Patricia A. Ganz , Susan Ann McCloskey , Soonmyung Paik , Nilendu Gupta , X. Allen Li , Dominic J. DiCostanzo , Walter John Curran Jr., Norman Wolmark

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Sign-In

Similar Posters

insert_chart_outlined

Poster

2017 ASCO Annual Meeting

bookmark_border

NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence free interval (IBCRFI) in patients (pts) with positive axillary (PAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC).

First Author: Eleftherios P. Mamounas

insert_chart_outlined

Poster

2016 ASCO Annual Meeting

bookmark_border

NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence free interval (IBCRFI) in patients (pts) with positive axillary (PAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC).

First Author: Eleftherios P. Mamounas

insert_chart_outlined

Poster

2015 ASCO Annual Meeting

bookmark_border

NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) will reduce invasive cancer events in patients (pts) with positive axillary (Ax) nodes who are ypN0 after neoadjuvant chemotherapy (NC).

First Author: Eleftherios P. Mamounas

insert_chart_outlined

Poster

2013 Breast Cancer Symposium

bookmark_border

Outcomes of sentinel lymph node–positive breast cancer patients treated with mastectomy without axillary therapy.

First Author: Elizabeth FitzSullivan